IBM Retirement Fund’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
FP
TP
IBM Retirement Fund's MRNA Position: Q2 2022 in Review
IBM Retirement Fund sold out of Moderna (MRNA) in Q2 2022, closing a stake of 5,400 shares — an estimated $930K sold.
IBM Retirement Fund first reported a position in MRNA in Q2 2020 and held it in 8 quarters. The position peaked at $3.68M in Q3 2021. 981 funds tracked by Wall St. Rank hold MRNA as of Q2 2022.
- IBM Retirement Fund reported no remaining Moderna position as of Q2 2022 after selling out during the quarter.
- IBM Retirement Fund sold 5,400 Moderna shares in Q2 2022, an estimated $930K.
- IBM Retirement Fund first reported a position in Moderna in Q2 2020 and held it in 8 quarters.
- IBM Retirement Fund's Moderna position peaked at $3.68M in Q3 2021.
- 981 funds tracked by Wall St. Rank held Moderna as of Q2 2022.
Based on IBM Retirement Fund's 13F filing for Q2 2022, filed 20 Jul 2022.